Phreesia, Inc. (NYSE:PHR) Shares Bought by Franklin Resources Inc.

Franklin Resources Inc. boosted its holdings in shares of Phreesia, Inc. (NYSE:PHR - Free Report) by 0.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,509,617 shares of the company's stock after buying an additional 11,986 shares during the quarter. Franklin Resources Inc. owned approximately 2.60% of Phreesia worth $37,982,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Norges Bank bought a new position in shares of Phreesia in the fourth quarter worth about $2,804,000. JPMorgan Chase & Co. raised its stake in Phreesia by 144.2% during the 4th quarter. JPMorgan Chase & Co. now owns 145,716 shares of the company's stock worth $3,666,000 after acquiring an additional 86,040 shares during the period. Vanguard Group Inc. lifted its holdings in Phreesia by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 4,823,110 shares of the company's stock valued at $121,349,000 after purchasing an additional 61,048 shares in the last quarter. LPL Financial LLC bought a new position in shares of Phreesia in the fourth quarter worth approximately $216,000. Finally, KLP Kapitalforvaltning AS purchased a new stake in shares of Phreesia in the fourth quarter worth $259,000. 92.10% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, CFO Balaji Gandhi sold 1,827 shares of the company's stock in a transaction that occurred on Wednesday, March 26th. The stock was sold at an average price of $27.46, for a total transaction of $50,169.42. Following the transaction, the chief financial officer now owns 103,591 shares of the company's stock, valued at approximately $2,844,608.86. This represents a 1.73 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, General Counsel Allison C. Hoffman sold 4,585 shares of the firm's stock in a transaction that occurred on Wednesday, January 15th. The stock was sold at an average price of $26.90, for a total value of $123,336.50. Following the sale, the general counsel now directly owns 154,552 shares of the company's stock, valued at $4,157,448.80. This represents a 2.88 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 150,227 shares of company stock worth $4,284,219 over the last three months. 5.80% of the stock is owned by insiders.

Phreesia Trading Down 5.5 %

PHR stock traded down $1.40 during midday trading on Thursday, reaching $23.81. 110,219 shares of the company traded hands, compared to its average volume of 432,456. The firm has a market capitalization of $1.40 billion, a price-to-earnings ratio of -16.21 and a beta of 0.82. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74. The business has a 50 day moving average of $26.75 and a 200-day moving average of $24.24. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $30.53.

Wall Street Analyst Weigh In

A number of research firms have commented on PHR. Citigroup raised their price target on Phreesia from $31.00 to $35.00 and gave the company a "buy" rating in a report on Friday, January 10th. Needham & Company LLC restated a "buy" rating and issued a $29.00 price target on shares of Phreesia in a research note on Thursday, March 13th. Piper Sandler reiterated an "overweight" rating and set a $33.00 price objective (up previously from $31.00) on shares of Phreesia in a research report on Wednesday, January 29th. Robert W. Baird cut their target price on shares of Phreesia from $34.00 to $30.00 and set an "outperform" rating for the company in a research note on Wednesday, December 11th. Finally, Royal Bank of Canada raised shares of Phreesia from a "sector perform" rating to an "outperform" rating and increased their price objective for the company from $24.00 to $32.00 in a report on Wednesday, January 8th. Twelve research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and an average price target of $31.33.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.